Apify builder
Leaderboard position
out of 10,354
New actors
#307
Total actors
#886
↑ +3,871
Monthly users
#1,423
↑ +3,589
Total users
#2,441
↑ +4,044
Monthly runs
#2,310
↑ +5,570
Total runs
#4,428
↑ +4,047
Portfolio stats
New actors
21
Total actors
21
↑ +20
Monthly users
21
↑ +20
Total users
42
↑ +40
Monthly runs
237
↑ +236
Total runs
355
↑ +350
New actors
Each bar shows one day in the last 30 days.
Portfolio concentration
17 of 21 actors cover 80%+ of monthly users.
Find newly recruiting ClinicalTrials.gov studies that match your site's therapeutic areas and geography. Get sponsor, eligibility, contact, location, and exact study evidence with replay-safe bounded charges.
5%
users
Monitor ClinicalTrials.gov for first-seen recruiting studies (NEW_TRIAL) and later material record changes (SOURCE_CORRECTION), with exact study links, replay suppression, and bounded charges.
5%
users
Check catalog brands, model numbers, and product terms against official U.S. CPSC recalls. Get source-linked new matches and material corrections for ecommerce compliance and product-safety monitoring.
5%
users
Monitor recent openFDA FAERS reports for literal matches to drug names or MedDRA reaction terms. Return only newly seen matching reports or changed source records, with bounded per-run charges.
5%
users
Internal screening aid for official openFDA food enforcement records: match products, suppliers, allergens, classifications, states, or distribution terms with exact source links, replay suppression, and bounded charges.
5%
users
Monitor Federal Register rules and notices for your agencies, industries, or policy terms. Built for compliance and government-affairs teams: receive source-linked new matches and material corrections while unchanged replays stay free.
5%
users
Turn the latest official Florida corporate filing file into replay-safe domestic formation leads with filing types, addresses, deterministic lead scores, exact source-file locators, and one bounded batch charge.
5%
users
Watch an explicit public GitHub repository allowlist for new releases and later source corrections. Get exact release links, notes, tags, prerelease flags, replay suppression, and bounded event charges.
5%
users
Turn Google Maps listing exports you already own into a replay-safe agency prospect feed. Identify missing, social-only, or free-builder websites and emit only new or changed qualified rows. This Actor qualifies supplied data; it does not scrape Google Maps.
5%
users
Monitor official NHTSA vehicle recalls for one make, model, and model year. Pay only for newly observed matching recalls or source corrections; unchanged replays are free.
5%
users
Monitor NWS active weather alerts against your counties, states, or alert types. Pay only for new alerts or material source corrections, not every raw entry.
5%
users
Match exact normalized name terms against the official OFAC SDN list, including parsed aliases, and receive source-linked new matches or later record corrections with replay suppression and bounded charges.
5%
users
Turn an explicit public RSS/Atom allowlist into canonical new-item and material-correction events without duplicate billing.
5%
users
Monitor official Seattle building permits and planning activity for new or changed development signals. Get source-linked, replay-safe events for construction, real-estate, and local business research.
5%
users
Monitor official SEC Schedule 13D and 13G filings by issuer-name term. Receive newly observed matching filings and changed indexed source records with bounded per-run charges.
5%
users
Monitor official SEC 8-K filings by ticker, CIK, and Item section. Receive new matches or source corrections with Item codes, exact filing links, replay suppression, and bounded event charges.
5%
users
Monitor official SEC Form 4 filings by ticker or CIK. Receive new matching filings or source corrections with trade details, exact filing links, replay suppression, and bounded event charges.
5%
users
ActorHunt MCP
ActorHunt gives paid members MCP access to keyword data, actor evidence, and Store movement for deciding what to build next.
